WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 38 filers reported holding WEREWOLF THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $204,394 | -21.6% | 95,511 | +11.7% | 0.01% | -16.7% |
Q2 2023 | $260,809 | +22.8% | 85,511 | +4.7% | 0.01% | 0.0% |
Q1 2023 | $212,449 | +26.8% | 81,711 | 0.0% | 0.01% | +50.0% |
Q4 2022 | $167,508 | -10.9% | 81,711 | +95.9% | 0.00% | -20.0% |
Q3 2022 | $188,000 | +27.0% | 41,711 | +15.2% | 0.01% | +66.7% |
Q2 2022 | $148,000 | – | 36,211 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DC Funds, LP | 589,102 | $10,274,000 | 48.81% |
MPM ASSET MANAGEMENT LLC | 4,284,172 | $74,716,000 | 13.89% |
MPM BioImpact LLC | 2,388,011 | $41,647,000 | 6.84% |
Soleus Capital Management, L.P. | 563,396 | $9,826,000 | 1.51% |
RA Capital Management | 4,291,881 | $74,850,000 | 1.20% |
SPHERA FUNDS MANAGEMENT LTD. | 706,294 | $12,049,000 | 0.82% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,552,787 | $44,521,000 | 0.79% |
Nicholas Investment Partners, LP | 294,654 | $5,139,000 | 0.32% |
Avidity Partners Management LP | 650,265 | $11,341,000 | 0.31% |
PFM Health Sciences, LP | 400,000 | $6,976,000 | 0.22% |